I catch myself smiling at a funny video on my phone while waiting in line at the pharmacy. Almost immediately, I feel a pang of…
Myeloma
Two clinical trials evaluating cemsidomide — an oral therapy candidate from C4 Therapeutics (C4T) that aims to limit cancer growth — in people with…
The U.S. Food and Drug Administration (FDA) has granted conditional approval to iberdomide, an oral medication to be used in combination with an antibody-based…
Remember my great plans to go walking regularly to combat chemo fog? “The best laid schemes o’ Mice an’ Men / Gang aft agley,” wrote…
I stand at the kitchen counter chopping vegetables for soup and hear my mum sigh from the living room. One might wonder how I can…
When glucose is scarce, fat cells can produce beta-OHB, a molecule that helps myeloma cells survive metabolic stress, a new study found. The study,…
I sometimes find inspiration for this column in surprising places. Tonight, I found it at the movie theater, during a showing of “Spider-Man:…
An international group of researchers is teaming up to develop a myeloma treatment that harnesses the cancer-killing abilities of natural killer (NK) cells. As…
I stand in the pharmacy aisle holding a packet of painkillers and feel time split in two. In one version, this is just a simple…
More than 40% of patients in a Phase 1 clinical trial of myeloma treatment cevostamab responded to the drug, meaning their cancer burden was…
Recent Posts
- Infection risk shifts over time with both CAR T and bispecific antibody therapy
- Building the quiet architecture of a caregiving day
- New CAR T-cell therapy shows promise in tough myeloma cases
- CAR T-cell therapy before surgery boosts glioblastoma control in mice
- Gynecologic Cancer Awareness Month urges education, action, and support